Skip to content
MARKETS / NYSE / OWLT
NYSE · MEASURING & CONTROLLING DEVICES, NEC · SMALL CAP

Owlet, Inc. OWLT

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$105.7M
▲ 35.4% YoY
$-39.7M
$-11.1M
In brief

What this company does

Owlet provides medically certified, over-the-counter wearable monitors that bring hospital-grade technology into the home. Dream Sock is a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, including pulse rate, oxygen level, activity, and sleep patterns. Dream Sock with Live Health Readings and Health Notifications has received FDA marketing authorization in the United States and regulatory clearances in the European Union, United Kingdom, Australia, South Africa, India, and Israel. BabySat, a prescription version of the wearable monitor, is FDA-cleared and available in the U.S. only. Since its inception, the company has sold over 2.5 million Owlet devices worldwide. Its products are widely available across major U.S. retailers, including Amazon, Baby List, Best Buy, Target, and Walmart. As of December 31, 2025, the company had 108 full-time employees and 6 part-time employees. Owlet Baby Care Inc. was incorporated in Delaware on February 24, 2014; following a July 2021 merger with SBG, which had been incorporated in Delaware in June 2020, SBG changed its name to Owlet, Inc.

Written from the business description in Owlet, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 9 March 2026. Every sentence was checked against that document before publication.

Growth
USD 105.7M
Revenue, FY2025 · full 6-year series below
Revenue $M Net income $M
FY2025 · Revenue 105.7 · Net income -39.7
40M80M-40M202020212022202320242025
Compound annual growth
+15.2%
+7.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +7.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−38 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -7.8% · Net -37.5%
-50%-100%202020212022202320242025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -11.1
-40M-80M202020212022202320242025

Total assetsUSD 85.6M
EquityUSD 19.0M
CashUSD 35.5M
Gross debtUSD 13.0M
Net debtUSD -22.4M
Current ratio1.85×

The company holds more cash than debt.

The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020
Revenue $B0.10.10.10.10.10.1
Operating income $B−0.0−0.0−0.0−0.1−0.1−0.0
EBITDA $B−0.0−0.0−0.0−0.1−0.1−0.0
Income tax $B0.00.00.00.00.00.0
Net income $B−0.0−0.0−0.0−0.1−0.1−0.0
Free cash flow $B−0.0−0.0−0.0−0.1−0.0−0.0
EPS, diluted $·−1.57−4.53−9.98−1.13−0.48
Dividend / sh $······
Payout %······
ROE %···−356.1··
Shares out B0.030.020.010.010.110.02

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 6 of 19 fiscal years. 65 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMeasuring & Controlling Devices, NEC
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2020

Share this section

Download image